- wöchentlichErscheinungsrhythmus
- 55 mintypische Länge
- vor 2 Tagenletzte Folge
Folgenzu den neuesten
Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On the Business of Biotech this week, Sahir Ali, Ph.D., founder and general partner at Modi Ventures, a family office investing at the
Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct cl
Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiral
Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Milan Kalawadia, CEO, North America, Dr. Reddy's Laboratories, and Arun Swaminathan, Ph.D., CEO, Coya Therapeut
How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Bill Holodnak, Cofounder and CEO of Occam Global, a life sciences executive recruitment firm (and occasional in
The Generalist Biotech CEO With Seekyo's Oury Chetboun
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Oury Chetboun, co-founder and CEO of Seekyo, a French biotech, talks about the range of experiences that prepar
Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix talks about his personal journe
Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an u
The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about disc
BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) This week's episode is one from the road, recorded in front of a live audience in Boston's Seaport neighborhood during the BIO conferen
How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Jennifer Hawks Bland, CEO of NewYorkBIO, shares insights on New York State's life sc
FDA Trials And Tribulations With Connect Biopharma's Barry Quart
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Barry Quart, CEO of Connect Biopharma, weighs in on the current state of engagement between drug developers and
Proactive Procurement Strategies For Biotech With Tom Wells
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Tom Wells, Director of Life Sciences at 4C Associates, reveals why -- and how -- sma
The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Thomas Levenson, MIT professor and author of So Very Small: How Humans Discovered The Microcosmos, Defeated Ger
Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Dr. Srinivas Rao, co-founder and CEO at atai Life Sciences, explains how his engineering background led him to
Biotech Angel Investing With Yaniv Sneor
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, explains how life sci
Leading A tRNA Startup With Alltrna's Michelle Werner
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna R
Executing A Product Pivot With Vir Bio's Mark Eisner, MD
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's
Commercializing RNAi Therapies With Alnylam's Tolga Tanguler
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On today's episode, Tolga Tanguler, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals, talks about commercializing RNAi thera
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On today's episode I'm speaking with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience
The Implications Of China's Growing Biotech Industry With Allan Shaw
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to gl
How To Be A CFO With Insmed's Sara Bonstein
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sa
Deal And Investment Trends With Investment Banker David Sans
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chem
Business of Biotech 2.0 with Ben Comer
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) After nearly five years as host of the Business of Biotech podcast, Matt Pillar is handing the mic over to the voice of the Business of
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latig
BoB@JPM: Kasper Roet, Ph.D., QurAlis
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Dr. Kasper Roet's hands-on work at the Dutch Brain Bank informed his leadership at the biotech QurAlis, where three clinical programs t
BoB@JPM: Rick Modi, Affinia Therapeutics
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this episode of the Business of Biotech, recorded on-site at the 2025 JP Morgan Healthcare Conference, we explore a new approach to
BoB@JPM: Tom Chalberg, Ph.D., Genascence
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Recorded in-person at the JP Morgan Healthcare Conference in San Franscisco, this episode finds Matt Pillar and Ben Comer exploring the
BoB@JPM: Ran Zheng, Landmark Bio
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Ran Zhang was hire number one at Landmark Bio back in 2021. Today, she's CEO of the 70+ employee cell and gene therapy manufacturer. We